Article Information
History
- April 20, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Welmoed van Loon1,*,
- Heike Rössig2,
- Susen Burock3,
- Jörg Hofmann4,
- Julian Bernhardt1,
- Elizabeth Linzbach1,
- Domenika Pettenkofer1,
- Christian Schönfeld1,
- Maximilian Gertler1,
- Joachim Seybold2,
- Tobias Kurth5 and
- Frank P. Mockenhaupt1
- 1Institute of Tropical Medicine and International Health, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- 2Medical Directorate, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- 3Charité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- 4Labor Berlin - Charité Vivantes GmbH, Berlin, Germany
- 5Institute of Public Health, Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany
- ↵*Corresponding author:
Welmoed van Loon, welmoed.van-loon{at}charite.de
Posted April 20, 2021.
Emergence of the SARS-CoV-2 B.1.1.7 lineage and its characteristics at an outpatient testing site in Berlin, Germany, January-March 2021
